T1D Exchange to Present Ten Studies Focused on Quality Improvement, Population Health and Real-World Evidence in Type 1 Diabetes at 80th American Diabetes Association Scientific Sessions
BOSTON–(BUSINESS WIRE)–T1D Exchange today announced that it will share data from ten abstracts, including six late breaking, focused on quality improvement, population health and real-world evidence and outcomes of people living with type 1 diabetes (T1D) at the American Diabetes Association (ADA) 80th Scientific Virtual Sessions. Two posters from the organization’s Quality Improvement Collaborative were recognized by healthcare information firm Close Concerns in its list of Top 50 Most Notable Posters.
T1D Exchange Announces Population Health Surveillance Study of COVID-19 in Individuals with Type 1 Diabetes
T1D Exchange today announced the launch of a population health surveillance study of individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). The results of the study will be used to better understand the etiology and potential outcomes in COVID-19 patients and inform future clinical quality improvement activities to better respond to the global pandemic.
Real World Evidence: What It Means and Why it Matters for Type 1 Diabetes
People living with type 1 diabetes learn, in many ways, to be research scientists and investigators of their own lives. We learn how slices of pizza or a plate of spaghetti affects our blood sugar, and how to mediate those effects with multiple boluses of insulin or a long-lasting dose. We discover precisely how much sugar we need to stay steady during an intense workout session.
In doing so, we begin to learn about the meaning and applications of real-world data and evidence. Modern medical and scientific research takes several different approaches to investigation, from randomized, controlled clinical trials to longitudinal, observational studies that examine how people live with various conditions and therapies in the real world.
T1D Exchange Study: Sleep Loss Reported as Most Frequent Daily Hurdle in Life with Type 1 Diabetes
Research on type 1 diabetes often centers on its health impacts, but people with type 1 diabetes have long said that such research only paints half of the picture, and that there are many more hidden costs to life with the condition.
T1D Exchange Registry – Our User-Friendly Way to Participate in Type 1 Diabetes Research
The T1D Exchange Registry is a collection of individuals with type 1 diabetes and their supporters who participate in research. Adults with type 1 diabetes or parents of children with type 1 diabetes can join by registering online, providing consent, and completing a short 28-question survey. Participants will then be asked to complete a similar questionnaire once a year. Once registered, participants will also have the ability to take part in more research opportunities in the future.
Join our mailing list for more about T1D
- Type 1 Diabetes Online Resources – September 2021by Samantha RobinsonSeptember 9, 2021
- T1D Exchange Appoints Two New Members to its Board of Directorsby Deborah TaylorSeptember 8, 2021
- Status Update: Automated Insulin Delivery Devicesby Hope WarshawSeptember 1, 2021
- Top Questions of the Day – August 2021by Sarah TackettAugust 31, 2021
- A Guide to CGMs and Medicaid Coverage Differences by Stateby Christine FallabelAugust 26, 2021